Persistence of Second and Third-Line Biologics in Inflammatory Bowel Disease: A Multi-Centre Cohort Study

• المؤلفون الرئيسيون: Timothy P. Hanrahan (مؤلف), Robbie Chan (مؤلف), Daniel Tassone (مؤلف), Nik S. Ding (مؤلف), Chamara Basnayake (مؤلف), Julien Schulberg (مؤلف), Abhinav Vasudevan (مؤلف), Michael Kamm (مؤلف), Michael De Gregorio (مؤلف), Daniel R. van Langenberg (مؤلف), Ola Niewiadomski (مؤلف)
• التنسيق: كتاب
• منشور في: MDPI AG, 2022-12-01T00:00:00Z.
• الموضوعات: article
• الوصول للمادة أونلاين: Connect to this object online.

Background: Despite proven efficacy of biologics in inflammatory bowel disease (IBD), many exhibit primary non-response or secondary loss of response and switch to subsequent biologic(s). Here, we identified early predictors of second- and/or third-line biologic persistence in IBD, in a real-world c...